Pharmafile Logo
Pharmafocus logo
Advanced Search

Industry awaits outcome of transparency legal challenge

July 16, 2015
Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …

News
ABPI

UK pharma made £41 million in doctor payments

July 16, 2015
Medical Communications, Sales and Marketing ABPI, ABPI Code, doctor payments

The pharma industry made £41m in payments to doctors, nurses and other healthcare professionals in the UK in 2014, the …

News
brandicourt

New Sanofi boss Brandicourt restructures global business

July 16, 2015
Sales and Marketing Oliver Brandicourt, Sanofi

Sanofi is reorganising its pharmaceuticals division to create three new business units from January 2016. Chief executive Oliver Brandicourt has …

News

Janssen sales follow J&J’s downward trend

July 15, 2015
Sales and Marketing J&J, JJ, Johnson & Johnson, Johnson and Johnson, financial results, olysio

Strong sales of its new hepatitis C treatment Olysio were not enough to stop a slump in profits at J&J’s …

News
Celgene

Celgene to acquire Receptos in $7.2bn deal

July 15, 2015
Sales and Marketing Celgene, Crohn's, Crohn’s disease, Receptos, acquisitions, crohn's disease, mergers, multiple sclerosis, ozanimod, relapsing multiple sclerosis, ulcerative colitis

Celgene has boosted its immune and inflammatory disease pipeline with the purchase of the biopharma company Receptos for $7.2 billion. …

News

MRC, GSK and universities team up on inflammatory diseases

July 15, 2015
Research and Development COPD, GSK, MRC, Medical Research Council, fibrosis, inflammatory diseases

UK pharma giant GSK is partnering with the Medical Research Council, to study the biological mechanisms behind common inflammatory diseases. …

News
anderw_mackie_picture

Ergomed strengthens management team and board

July 15, 2015
Research and Development, Sales and Marketing Andrew Mackie, ergomed

UK-based drug development company Ergomed has appointed Andrew Mackie as chief business officer, and to its board as executive director.Mackie …

Appointment
The Francis Crick Institute

GSK and the Francis Crick Institute collaborate on drug R&D

July 15, 2015
Research and Development Francis Crick Institute, GSK, R&D, The Crick, medical research

The UK’s largest pharma company and the UK’s newest biomedical research facility are partnering up to begin an innovation collaboration.The …

News
Public Health England

Public Health England and Imperial Innovations boost UK life sciences sector

July 14, 2015
Manufacturing and Production, Research and Development Imperial Innovations, Public Health England, R&D, investment, life sciences, spin-puts

The Government has signed-off on the transfer of Public Health England’s drug development and production arm into a state-owned biopharma …

News
Life sciences minister George Freeman

Government launches Accelerated Access Review call to action

July 14, 2015
Research and Development Accelerated Access Review, Sir Hugh Taylor, UK, george freeman, john bell, life sciences minister

The Government is urging pharma companies to participate in the Accelerated Access Review, and will launch a website for firms …

News
Rexulti (brexpiprazole)

FDA approves Lundbeck and Otsuka’s Rexulti for depression

July 14, 2015
Sales and Marketing FDA, Lundbeck, Otsuka, Rexulti, US, brexpiprazole, depression, major depressive disorder, schizophrenia

Lundbeck and Otsuka have gained a yes vote from the FDA for their jointly-marketed antidepressant, Rexulti. The US regulator approved …

News

Chancellor announces drug R&D funding boost in Catapult expansion

July 14, 2015
Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy

Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …

News
Actavis facility in Iceland

Allergan closing manufacturing facility in Iceland

July 14, 2015
Manufacturing and Production Actavis, Allergan, Iceland, manufacturing, production, redundancies

Actavis is shutting a plant in Iceland, where its recently-acquired company Actavis has roots, and cutting 300 jobs in the …

News

Pharma companies look to Apple’s ResearchKit for R&D

July 13, 2015
Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit

Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …

News
Astellas' Ken Jones

Diary of a decade – Ten years in Europe, the Middle East and Africa

July 13, 2015
Medical Communications, Sales and Marketing Astellas, Ken Jones

It’s hard to imagine how much a company can change in a decade.When Astellas Pharma Europe was launched 10 years …

Feature
roche__tree

Roche posts positive mid-stage trial results for atezolizumab

July 13, 2015
Research and Development Genentech, PD-L1, Phase II, Roche, anti-PD-L1, atezolizumab, clinical trial, immuno-oncology, personalised medicine

A cancer drug in development by Roche has performed well in a mid-phase clinical trial – prompting the Swiss firm …

News

Novo Nordisk pushes forward with new diabetes drug trial

July 13, 2015
Research and Development GLP-1 agonist, Novo Nordisk, diabetes, phase III, semaglutide, type 2 diabetes

Novo Nordisk is taking the first steps towards adding another type 2 diabetes drug to its portfolio, after announcing positive …

News
Daiichi Sankyo

NICE recommends Daiichi’s Lixiana for blood clots

July 13, 2015
Sales and Marketing DVT, Daiichi, Daiichi Sankyo, Lixiana, NICE, NOACs, VTE, anticoagulant, blood clots, edoxaban, novel anticoagulant. PE

Daiichi Sankyo has won a speedy approval from NICE, after the NHS guidance body approved its newly-launched blood clotting drug …

News
6127242068_23c80ef94f_z

Pharma dominates global M&A activity

July 10, 2015
Sales and Marketing M&A, MA, acquisitions, mergers, takeovers

Mergers and acquisitions in the pharma, medical and biotech sectors have hit the highest levels in nearly 15 years, a …

News
Entyvio

NICE u-turns on Entyvio for Crohn’s disease

July 10, 2015
Medical Communications, Sales and Marketing Crohn's, Crohn’s disease, Entyvio, Millenium, NICE, Takeda, funding

NICE has performed a u-turn and recommended drug treatment Entyvio for Crohn’s disease for routine NHS funding.In final draft guidance …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026